Research
Hormonal
Semaglutide is endorsed as a secondary treatment for improving glycemic control in type 2 diabetes mellitus (T2DM).
Practitioners can consider semaglutide as a secondary option for patients with T2DM to improve blood sugar control.
StrongSupportsmedium confidence
It has been endorsed as a secondary treatment for improving glycemic control in T2DM.
Why this rating
The abstract suggests a strong endorsement for the treatment based on studies.
Source
Utilizing Semaglutide for Addressing Type-2 Diabetes and Obesity
Raghav Gupta et al. · Current Signal Transduction Therapy · 2025
otherCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →